2-({6-[(6-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
Structure Info
- Chemspace ID
- CSCS02515421354 (Synthesis)
- MFCD
- MFCD00151164
- IUPAC Name
- 2-({6-[(6-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
- Mol formula
- C30H52O26
- Mol weight
- 829 Da
- Catalog Number(s)
- M18458, OC04683
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -10.02
- Heavy atoms count
- 56
- Rotatable bond count
- 13
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 1
- Polar surface area (Å)
- 427
- Hydrogen bond acceptors count
- 26
- Hydrogen bond donors count
- 17
- Zoom the structure
- CSCS02515421354
Items Overall 10 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Molnova Chemicals | 10 days | United States To: | 98 | 5 mg | 38.50 | |
| Molnova Chemicals | 10 days | United States To: | 98 | 10 mg | 63.80 | |
| Molnova Chemicals | 10 days | United States To: | 98 | 25 mg | 104.50 | |
| Molnova Chemicals | 10 days | United States To: | 98 | 50 mg | 151.80 | |
| Molnova Chemicals | 10 days | United States To: | 98 | 100 mg | 226.60 | |
Description: Maltopentaose; CAS: 34620-76-3 | ||||||
| Biosynth | 30 days | United Kingdom To: | 95 | 10 mg | 435.60 | |
| Biosynth | 30 days | United Kingdom To: | 95 | 25 mg | 980.10 | |
| Biosynth | 30 days | United Kingdom To: | 95 | 50 mg | 1,633.50 | |
| Biosynth | 30 days | United Kingdom To: | 95 | 100 mg | 2,613.60 | |
| Biosynth | 30 days | United Kingdom To: | 95 | 250 mg | 5,227.75 | |
Description: D-Cellopentaose; CAS: 2240-27-9 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire